EMMAC Life Sciences

About:

EMMAC is a medical cannabis company that works to join together the latest science and research with cutting-edge cultivation.

Website: https://www.emmac.com/

Twitter/X: emmaclsg

Top Investors: Measure 8 Venture Partners, Material V

Description:

EMMAC is a medical cannabis company that works to join together the latest science and research with cutting-edge cultivation, extraction, and production. It has developed unique supply and distribution partnerships across Europe to establish itself not only as a thought leader at the very forefront of research into the medical benefits of cannabis but also as a European leader in the production and supply of medical cannabis, hemp, and other derivatives products. It was founded in 2018 and is headquartered in London, England.

Total Funding Amount:

$25.6M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2018-01-01

Contact Email:

enquiries(AT)emmac.com

Founders:

Antonio Costanzo, Ed McDermott

Number of Employees:

51-100

Last Funding Date:

2020-12-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai